Sage Therapeutics Inc.

NASDAQ: SAGE · Real-Time Price · USD
6.78
0.24 (3.67%)
At close: Jun 05, 2025, 3:59 PM
6.78
0.07%
After-hours: Jun 05, 2025, 04:04 PM EDT

Sage Therapeutics Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Collaboration Revenue Related Party Revenue 36.09M 824K 7.69M 6.31M 6.7M 3.96M
Collaboration Revenue Related Party Revenue Growth +4279.49% -89.28% +21.85% -5.85% +69.32% n/a
Other Collaboration Revenue Revenue 1.58M 177K n/a n/a n/a n/a
Other Collaboration Revenue Revenue Growth +793.79% n/a n/a n/a n/a n/a
Product Revenue 3.57M 10.45M n/a n/a n/a n/a
Product Revenue Growth -65.81% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 57.59M 54.65M 53.22M 55.98M 51.98M 55.11M 78.14M 75.56M 65.71M 67.33M 61.48M 52.41M 46.48M 51.6M 48.71M 43.35M 39.85M 53.5M 35.1M 38.22M 70.13M 85.13M 88.5M 88.23M 83.92M 75.69M 53.69M 43.17M 28.85M 19.56M 16.09M 14.95M 12.28M 14.38M 8.99M 8.91M 7.13M 8.24M 6.6M 6.46M 4M
Selling, General, and Administrative Revenue Growth +5.39% +2.68% -4.94% +7.71% -5.68% -29.48% +3.41% +15.00% -2.41% +9.51% +17.31% +12.77% -9.93% +5.94% +12.37% +8.78% -25.52% +52.42% -8.18% -45.50% -17.62% -3.81% +0.31% +5.13% +10.86% +40.98% +24.38% +49.63% +47.50% +21.58% +7.58% +21.78% -14.57% +59.92% +0.89% +24.91% -13.39% +24.71% +2.29% +61.52% n/a
Research and Development Revenue 22.76M 37.02M 54.58M 62.56M 71.73M 64.33M 101.92M 97.16M 92.83M 89.3M 81.55M 77.3M 78.02M 75.44M 83.5M 66.17M 58.06M 81.71M 74.08M 73.32M 63.61M 91.25M 102.11M 89.06M 86.4M 88.81M 75.05M 68.98M 49.27M 50.89M 58.29M 55.9M 45.2M 42M 29.07M 26.1M 23.58M 20.38M 17.48M 18.6M 12.9M
Research and Development Revenue Growth -38.52% -32.17% -12.77% -12.78% +11.51% -36.88% +4.90% +4.67% +3.95% +9.49% +5.51% -0.92% +3.41% -9.65% +26.19% +13.98% -28.95% +10.30% +1.03% +15.26% -30.29% -10.63% +14.65% +3.08% -2.71% +18.32% +8.80% +40.00% -3.18% -12.69% +4.27% +23.67% +7.61% +44.47% +11.42% +10.67% +15.73% +16.58% -6.05% +44.21% n/a